CardioGenics Holdings Inc
CGNH
$0.0001
$0.000.00%
| 01/31/2016 | 10/31/2015 | 07/31/2015 | 04/30/2015 | 01/31/2015 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 32.28% | 19.93% | -82.39% | -79.53% | -78.78% |
| Depreciation & Amortization | -33.65% | -30.19% | -2.54% | 3.47% | 0.96% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.31% | -20.70% | -67.21% | -63.60% | -61.28% |
| Operating Income | 16.31% | 20.70% | 67.21% | 63.60% | 61.28% |
| Income Before Tax | 70.57% | 28.49% | 16.45% | 11.46% | -7.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 70.57% | 28.49% | 16.45% | 11.46% | -7.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 70.57% | 28.49% | 16.12% | 11.03% | -7.66% |
| EBIT | 16.31% | 20.70% | 67.21% | 63.60% | 61.28% |
| EBITDA | 15.89% | 20.47% | 67.75% | 64.18% | 61.83% |
| EPS Basic | 81.96% | 47.76% | 32.08% | 21.86% | 5.85% |
| Normalized Basic EPS | 81.67% | 47.55% | 25.30% | 13.59% | -4.71% |
| EPS Diluted | 76.36% | 48.32% | 36.61% | 32.30% | 5.82% |
| Normalized Diluted EPS | 81.35% | 47.17% | 25.00% | 13.27% | -4.71% |
| Average Basic Shares Outstanding | 60.61% | 52.90% | 36.44% | 22.88% | 13.00% |
| Average Diluted Shares Outstanding | 66.04% | 58.66% | 42.36% | 28.92% | 13.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
